Nov 20, 2019
Archives: News
Oct 29, 2019
Salarius, Aspire Capital announce a $10.9M stock purchase agreement
Oct 29, 2019
Houston pharma co. lands nearly $11M investment from Chicago group
Oct 23, 2019
Salarius Believes Children Should Not Be Left Behind in the Fight Against Cancer
Oct 22, 2019
David Arthur discusses Seclidemstat with Bio Tuedays
Jul 30, 2019
Salarius’ CEO David Arthur Nasdaq Introduction
Jul 30, 2019
Salarius Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell
Jul 30, 2019
SALARIUS PHARMACEUTICALS, INC. RINGS THE NASDAQ STOCK MARKET OPENING BELL
Jul 20, 2019
Salarius’ CEO David Arthur on the Fight Against Cancer
Mar 29, 2019